Neuroscience
Central nervous system dysfunction is pivotal to many chronic human diseases. Aquila has established expertise in models supporting the selection of analgesics, with particular focus across acute and chronic nociceptive conditions. A wide range of models including tailflick, inflammatory pain (Carrageenan, CFA), formalin, visceral, neuropathic pain (SNL, CCI, SNI, VZV) and bone cancer pain can be provided for early proof-of-concept efficacy development.
Contact us for more information